Publication

AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications.

Journal Paper/Review - Jan 6, 2022

Units
PubMed
Doi
Contact

Citation
Notter J, Seiffert S, Zimmermann-Kogadeeva M, Bösch A, Wenger R, Strahm C, Frischknecht M, Livermore D, Babouee Flury B. AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications. BMC Infect Dis 2022; 22:33.
Type
Journal Paper/Review (English)
Journal
BMC Infect Dis 2022; 22
Publication Date
Jan 6, 2022
Issn Electronic
1471-2334
Pages
33
Brief description/objective

Data on antimicrobial resistance mechanisms are scanty for Cedecea spp., with very variable antibiotic resistance patterns documented. Here we report the first in vivo resistance evolution of a C. davisae clinical isolate in a patient with a complex hand trauma and provide insight in the resistance mechanism, leading to therapeutic implications for this pathogen.